NYSE:OGN

PT. Organon Pharma Indonesia Tbk.

Stock

USD

Last Close

6.71

06/11 22:31

Market Cap

5.12B

Beta: -

Volume Today

29.84M

Avg: 2.10M

PE Ratio

7.03

PFCF: 9.70

Dividend Yield

6.96%

Payout:50.26%

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	2.15B -	3.31B 53.55%	2.16B 34.66%	1.35B 37.45%	917M 32.12%	1.02B 11.56%
depreciation and amortization	1.67B -	333M 80.10%	157M 52.85%	195M 24.20%	212M 8.72%	236M 11.32%
deferred income tax	37M -	12M 67.57%	6M 50%	-288M 4,900%	-18M 93.75%	-485M 2,594.44%
stock based compensation	56M -	41M 26.79%	54M 31.71%	59M 9.26%	75M 27.12%	101M 34.67%
change in working capital	-174M -	-672M 286.21%	-197M 70.68%	702M 456.35%	-452M 164.39%	-155M 65.71%
accounts receivables	250M -	200M 20%	159M 20.50%	-277M 274.21%	-123M 55.60%	-212M 72.36%
inventory	44M -	-91M 306.82%	-29M 68.13%	-138M 375.86%	-220M 59.42%	-230M 4.55%
accounts payables	20M -	-35M 275%	27M 177.14%	663M 2,355.56%	-237M 135.75%	163M 168.78%
other working capital	-488M -	-746M 52.87%	-354M 52.55%	454M 228.25%	128M 71.81%	124M 3.13%
other non cash items	-58M -	-253M 336.21%	7M 102.77%	439M 6,171.43%	124M 71.75%	79M 36.29%
net cash provided by operating activities	3.69B -	2.77B 24.95%	2.19B 20.96%	2.46B 12.39%	858M 65.09%	799M 6.88%
investments in property plant and equipment	-101M -	-92M 8.91%	-278M 202.17%	-488M 75.54%	-427M 12.50%	-261M 38.88%
acquisitions net		7M -	5M 28.57%	-185M 3,800%	-124M 32.97%	-2M 98.39%
purchases of investments
sales maturities of investments
other investing activites	32M -	-17M 153.13%	15M 188.24%	192M 1,180%	131M 31.77%	3M 97.71%
net cash used for investing activites	-69M -	-102M 47.83%	-258M 152.94%	-481M 86.43%	-420M 12.68%	-260M 38.10%
debt repayment		-44M -	-79M 79.55%	-1.62B 1,955.70%	-108M 93.35%	-338M 212.96%
common stock issued					11M -
common stock repurchased					-11M -
dividends paid				-145M -	-290M 100%	-294M 1.38%
other financing activites	-4.16B -	-2.58B 38.11%	-2.10B 18.67%	436M 120.80%	-35M 108.03%	63M 280%
net cash used provided by financing activities	-4.16B -	-2.62B 37.06%	-2.17B 17.02%	-1.33B 38.71%	-433M 67.52%	-569M 31.41%
effect of forex changes on cash	19M -	31M 63.16%	-3M 109.68%	23M 866.67%	-36M 256.52%	17M 147.22%
net change in cash	-527M -	75M 114.23%	-249M 432%	667M 367.87%	-31M 104.65%	-13M 58.06%
cash at beginning of period	771M -	244M 68.35%	319M 30.74%	70M 78.06%	737M 952.86%	706M 4.21%
cash at end of period	244M -	319M 30.74%	70M 78.06%	737M 952.86%	706M 4.21%	693M 1.84%
operating cash flow	3.69B -	2.77B 24.95%	2.19B 20.96%	2.46B 12.39%	858M 65.09%	799M 6.88%
capital expenditure	-101M -	-92M 8.91%	-278M 202.17%	-488M 75.54%	-427M 12.50%	-261M 38.88%
free cash flow	3.59B -	2.67B 25.40%	1.91B 28.64%	1.97B 3.20%	431M 78.12%	538M 24.83%

All numbers in USD (except ratios and percentages)